| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8209611 | Applied Radiation and Isotopes | 2015 | 5 Pages |
Abstract
This review compares the safety and efficacy of boron neutron capture therapy (BNCT) in the treatment of previously irradiated, inoperable locoregional recurrent HNC patients and compares BNCT against the standard treatment of platinum-based chemotherapy. Our analysis of published clinical trials highlights efficacy of BNCT associated with mild side effects. However, the use of BNCT should be explored in stratified randomised trials.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Diana Lim, Daniel SC Quah, Michelle Leech, Laure Marignol,